ENDOMETRIAL CANCER METASTATIC

ENDOMETRIAL CANCER METASTATIC was reported 162 times

ENDOMETRIAL CANCER METASTATIC is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Interleukin-5 Antagonist [EPC] 1 0.0015
1 Leptin Analog [EPC] 1 0.0008
2 alpha-Hydroxy Acid [EPC] 1 0.0005
3 alpha-Glucosidase Inhibitor [EPC] 1 0.0002
4 Programmed Death Receptor-1 Blocking Antibody [EPC] 13 0.0001
5 Progesterone [EPC] 3 0.0001
6 Nuclear Export Inhibitor [EPC] 1 0.0001
7 Microtubule Inhibitor [EPC] 16 0.0001
8 Estrogen [EPC] 18 0.0001
9 Anti-anginal [EPC] 1 0.0001
10 Aromatase Inhibitor [EPC] 9 0.0001
11 Androgen [EPC] 2 0.0001
12 Provitamin D2 Compound [EPC] 2 0.0001
13 Platinum-based Drug [EPC] 16 0.0001
14 Carbonic Anhydrase Inhibitor [EPC] 1 0.0000
15 Thiazide-like Diuretic [EPC] 2 0.0000
16 Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor [EPC] 1 0.0000
17 RANK Ligand Inhibitor [EPC] 9 0.0000
18 Vascular Endothelial Growth Factor Inhibitor [EPC] 8 0.0000
19 Epidermal Growth Factor Receptor Antagonist [EPC] 2 0.0000
20 Serotonin-1b and Serotonin-1d Receptor Agonist [EPC] 1 0.0000
21 Prostacycline Vasodilator [EPC] 5 0.0000
22 Integrin Receptor Antagonist [EPC] 3 0.0000
23 Soluble Guanylate Cyclase Stimulator [EPC] 1 0.0000
24 Angiotensin Converting Enzyme Inhibitor [EPC] 4 0.0000
25 Interleukin-17A Antagonist [EPC] 1 0.0000
26 HER2/neu Receptor Antagonist [EPC] 2 0.0000
27 Non-Standardized Chemical Allergen [EPC] 2 0.0000
28 Kinase Inhibitor [EPC] 14 0.0000
29 Estrogen Receptor Antagonist [EPC] 1 0.0000
30 Amide Local Anesthetic [EPC] 2 0.0000
31 Histamine-2 Receptor Antagonist [EPC] 3 0.0000
32 Phosphodiesterase 5 Inhibitor [EPC] 3 0.0000
33 Muscle Relaxant [EPC] 1 0.0000
34 Antiarrhythmic [EPC] 2 0.0000
35 Ester Local Anesthetic [EPC] 1 0.0000
36 Endothelin Receptor Antagonist [EPC] 4 0.0000
37 Janus Kinase Inhibitor [EPC] 3 0.0000
38 Central alpha-2 Adrenergic Agonist [EPC] 1 0.0000
39 Opioid Agonist [EPC] 5 0.0000
40 Folate Analog Metabolic Inhibitor [EPC] 8 0.0000
41 Complement Inhibitor [EPC] 1 0.0000
42 Peroxisome Proliferator Receptor alpha Agonist [EPC] 1 0.0000
43 Progestin [EPC] 5 0.0000
44 Nicotinic Acid [EPC] 1 0.0000
45 Dihydropyridine Calcium Channel Blocker [EPC] 5 0.0000
46 Nitroimidazole Antimicrobial [EPC] 1 0.0000
47 Factor Xa Inhibitor [EPC] 4 0.0000
48 Expectorant [EPC] 3 0.0000
49 Thiazide Diuretic [EPC] 3 0.0000
50 Selective T Cell Costimulation Modulator [EPC] 2 0.0000
51 alpha-Adrenergic Blocker [EPC] 2 0.0000
52 Potassium Channel Blocker [EPC] 1 0.0000
53 Calcium [EPC] 2 0.0000
54 Insulin Analog [EPC] 6 0.0000
55 beta-Adrenergic Blocker [EPC] 4 0.0000
56 Aldosterone Antagonist [EPC] 2 0.0000
57 Nucleoside Analog Antiviral [EPC] 1 0.0000
58 Interferon beta [EPC] 2 0.0000
59 Proton Pump Inhibitor [EPC] 6 0.0000
60 Osmotic Laxative [EPC] 3 0.0000
61 Aminosalicylate [EPC] 1 0.0000
62 Vitamin D [EPC] 3 0.0000
63 Interleukin-12 Antagonist [EPC] 1 0.0000
64 Interleukin-23 Antagonist [EPC] 1 0.0000
65 Antirheumatic Agent [EPC] 1 0.0000
66 Vitamin B12 [EPC] 3 0.0000
67 Nonsteroidal Anti-inflammatory Drug [EPC] 12 0.0000
68 Parathyroid Hormone Analog [EPC] 1 0.0000
69 Loop Diuretic [EPC] 4 0.0000
70 Benzodiazepine [EPC] 6 0.0000
71 P2Y12 Platelet Inhibitor [EPC] 1 0.0000
72 Sulfonylurea [EPC] 1 0.0000
73 HMG-CoA Reductase Inhibitor [EPC] 3 0.0000
74 Tumor Necrosis Factor Blocker [EPC] 8 0.0000
75 Calcineurin Inhibitor Immunosuppressant [EPC] 1 0.0000
76 Thalidomide Analog [EPC] 4 0.0000
77 Interleukin-6 Receptor Antagonist [EPC] 1 0.0000
78 Vitamin C [EPC] 3 0.0000
79 Leukocyte Growth Factor [EPC] 1 0.0000
80 Platelet Aggregation Inhibitor [EPC] 4 0.0000
81 Angiotensin 2 Receptor Blocker [EPC] 2 0.0000
82 Corticosteroid [EPC] 8 0.0000
83 Phosphodiesterase 4 Inhibitor [EPC] 1 0.0000
84 GLP-1 Receptor Agonist [EPC] 2 0.0000
85 Alkylating Drug [EPC] 1 0.0000
86 CD20-directed Cytolytic Antibody [EPC] 1 0.0000